Latest News

Date Title Topic
08 Nov 2016 Media Alert: ESMO Asia 2016 – Cancer Experts Meet in Singapore from 16 to 19 December 2016
Webcasts
07 Nov 2016 Personalised Cancer Vaccines Cancer Immunology and Immunotherapy
04 Nov 2016 KEYNOTE-045 Study Meets Primary Endpoint and Stops Early Genitourinary cancers - Cancer Immunology and Immunotherapy
03 Nov 2016 Now Available in Russian, the ESMO/ACF Patient Guide on Pancreatic Cancer
03 Nov 2016 NICE Does Not Recommend Cobimetinib in Combination With Vemurafenib Melanoma and other skin tumours - Anticancer agents & Biologic therapy
Elections
02 Nov 2016 Withdrawal of the Marketing Authorisation Application for Pemetrexed (as ditromethamine) Hospira Lung and other thoracic tumours - Anticancer agents & Biologic therapy
31 Oct 2016 NICE Recommends Osimertinib for Advanced EGFR T790M Mutation-Positive NCSLC Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
28 Oct 2016 Media Alert: ESMO Symposium on Immuno-Oncology 2016 Cancer Immunology and Immunotherapy
28 Oct 2016 FDA Approves Pembrolizumab for First-Line Treatment of Metastatic NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
27 Oct 2016 EMA Recommends a Change to the Terms of the Marketing Authorisation for Arsenic Trioxide Haematologic malignancies - Anticancer agents & Biologic therapy
26 Oct 2016 Off-Label Drug Coverage in Oncology Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
24 Oct 2016 FDA Grants Accelerated Approval to New Treatment for Advanced STS Sarcomas - Anticancer agents & Biologic therapy
24 Oct 2016 FDA Modifies Indication for Erlotinib in NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy